SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)
KDUS 1.6000.0%Jul 2 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (171)5/7/2000 6:50:00 AM
From: dalroi  Read Replies (1) of 1833
 
Nice to comperare with previous statement

AMOUNT AND NATURE PERCENTAGE OF OUTSTANDING
NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIAL OWNERSHIP OWNED(2)
------------------------------------------------------------------- -------------------- -------------------------

Carl C. Icahn** ................................................... 3,367,216(3) 25.75%
767 Fifth Avenue
New York, New York 10153

Bristol-Myers Squibb .............................................. 2,061,673 15.78%
P.O. Box 4000
Route 206 and Province Line Road
Princeton, New Jersey 08543-4000

Physica B.V. (4) .................................................. 1,599,942 12.24%
C.J. van Houtenlaan 36
1381 CP Weesp
The Netherlands

International Biotechnology Trust plc ............................. 850,000(5) 6.50%
c/o Rothschild Asset Management Limited
Five Arrows House
St. Swithins Lane
London EC4N 8NR
United Kingdom

SmithKline Beecham Corporation .................................... 660,962(6) 5.06%
One Franklin Plaza
Philadelphia, PA 19102

Charles Woler** ................................................... * *

Philip N. Sussman.................................................. 137,363(7) 1.04%

David R. Webb, Ph.D................................................ 72,917(8) *

Arlindo L. Castelhano, Ph.D........................................ 22,334(9) *

James S. Rielly.................................................... 15,618(10) *

Jeremy M. Levin, D. Phil., MB. BCHIR............................... 290,071(11) 2.17%

Theodore Altman**.................................................. 6,000(12) *

James R. Broach**.................................................. 203,668(13) 1.55%

Harold First**..................................................... 16,834(14) *

Russell D. Glass**................................................. -- *

William H. Koster, Ph.D............................................ 2,061,673(15) 15.78%

Peter S. Liebert, M.D.**........................................... 14,334(16) *

Robert J. Mitchell**............................................... 6,000(17) *

Siegfried G. Schaefer, Ph.D.**..................................... 1,599,942(18) 12.24%

Nicole Vitullo**................................................... 8,500(19) *

Samuel D. Waksal, Ph.D.**.......................................... 6,000(20) *

Jack G. Wasserman**................................................ 8,500(21) *


2

NUMBER OF SHARES
AMOUNT AND NATURE PERCENTAGE OF OUTSTANDING
NAME AND ADDRESS OF BENEFICIAL OWNER(1) BENEFICIAL OWNERSHIP OWNED(2) ------------------------------------------------------------------- ---------- -----

All executive officers and directors as a group (17 persons)....... 7,836,970
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext